Collective Expert Perspectives on the Use of Safinamide as Adjunctive Therapy for Parkinson's Disease: Online-Based Delphi Survey
Sign Up to like & getrecommendations! Published in 2022 at "Parkinson's Disease"
DOI: 10.1155/2022/3203212
Abstract: Background Safinamide is a selective, reversible monoamine oxidase-B inhibitor with a sodium channel inhibitory effect. Published clinical evidence supports safinamide as an effective therapy for Parkinson's disease (PD) with wearing-off. However, to date, no consensus… read more here.
Keywords: parkinson disease; use safinamide; expert perspectives; perspectives use ... See more keywords